Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | SHPH | COMMON STOCK | 1.07M | Aug 29, 2022 | Direct | F1 |
Id | Content |
---|---|
F1 | The undersigned became a Reporting Person subject to Section 16 reporting on August 29, 2022, the date on which Shuttle Pharmaceuticals Holdings, Inc. ("Company") completed its initial public offering ("Offering"). At the time of the Offering, the Reporting Person was the beneficial owner of 1,073,526 shares of common stock of the Company, consisting of (i) 1,070,824 shares of common stock and (ii) 2,702 restricted stock units, all of which have fully vested. |